Sonoma Pharmaceuticals Inc 's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Sonoma Pharmaceuticals Inc 's ROA in the first quarter of 2026?
Sonoma Pharmaceuticals Inc recorded a cumulative net loss of $-2 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -15.21%.

However, within the Healthcare sector 392 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 3642 to 4155.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Total Assets Change	25.67 %	1.95 %	-7.1 %	2.29 %	5.38 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-2	-3	-3	-3	-4
Return On Assets (TTM)	-15.21 %	-22.74 %	-24.25 %	-24.58 %	-25.25 %
SNOA's Total Ranking	# 4155	# 3642	# 3688	# 3739	# 4369
Total Assets (TTM) in million	18	14	14	14	14
Seq. Total Assets Change	29.71 %	1.95 %	-0.67 %	-4.32 %	5.22 %
Seq. Net Income Change	-	-	-	-	-

SNOA's 5 Years Annual ROA >> Back to SNOA Management Effectiveness >> Compare SNOA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 117
Sector	# 393
Overall	# 3895

Return On Assets Statistics
High	Average	Low
73.09 %	-34.76 %	-120.07 %
(Dec 31 2016)		(Mar 31 2012)

Financial Statements
Sonoma Pharmaceuticals Inc 's Assets	$ 18 million	SNOA's Balance sheet
Sonoma Pharmaceuticals Inc 's Income	$ 0 million	Quarterly SNOA's Income Statement
SNOA's Income by Division		See SNOA's Income by Division

Annual Return On Assets	(Mar 31 2026) FY 2026	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022
Y / Y Total Assets Change	1.95 %	-7.1 %	-9.19 %	-13.43 %	25.11 %
Total Assets in million	14	14	15	16	19
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	-3	-5	-5	-5
Annual Return On Assets	0.02 %	-25.25 %	-32.8 %	-31.74 %	-27.13 %

SNOA's 5 Years Annual ROA >> Back to SNOA Management Effectiveness >> Compare SNOA ROA to its Competitors

Comment on SNOA's ROA in the fiscal year ending 2026

In the fiscal year 2026 ROA improved to 0.02 % compared to prior year, due to annual net income growth of % to $0.00 million, while value of Sonoma Pharmaceuticals Inc 's overall assets grew just by 1.95 % to $13.96 million, compared to $13.96 a year before.

More Return On Assets Ratios
SNOA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SNOA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SNOA's Competitors
Subscribers only: Roa for Sonoma Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for SNOA's Customers

You may also want to know
SNOA's Roi	SNOA's Inventory Turnover Ratio	SNOA's Growth Rates	SNOA's Dividend Comparisons
	SNOA's Profitability Ratios	SNOA's Asset Turnover Ratio	SNOA's Dividend Growth
SNOA's Roe	SNOA's Valuation Ratios	SNOA's Financial Strength Ratios	SNOA's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-05T15:31:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.